KPC Pharmaceuticals,Inc financials at a glance

+ Portfolio

The revenue of KPC Pharmaceuticals,Inc is reported as 7.70312 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0.44 Yuan Renminbi per share in 2023, which was 2.33 higher than 2020. And about 0.2906 billion Yuan Renminbi are reported as free cash flow in the financials of KPC Pharmaceuticals,Inc 2023. Dividends of 0.2 Yuan Renminbi per share were paid to shareholders of KPC Pharmaceuticals,Inc stock SHSE:600422 in fiscal 2023.

¥7.70B

Revenue

¥0.44

Earnings Per Share

44.26%

Gross Margin %

¥0.00M

Free Cash Flow

Revenue

7,703.12

Earnings Per Share

0.44

Gross Margin %

44.26

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2020	2016	2015	2013	2012	2011	2010	2009
Rev.	Revenue	N/A	¥7.70B	¥7.72B	¥5.10B	¥4.92B	¥3.58B	¥3.02B	¥2.43B	¥1.82B	¥1.43B
GM %	Gross Margin %	42.87%	44.26%	42.87%	38.59%	34.42%	29.08%	31.76%	29.64%	32.52%	35.10%
OM	Operating Margin	5.63%	6.28%	6.68%	7.86%	9.55%	7.99%	7.84%	7.35%	6.48%	5.94%
EPS	Earnings Per Share	¥0.53	¥0.44	¥0.43	¥0.40	¥0.53	¥0.33	¥0.26	¥0.19	¥0.13	¥0.09
Div.	Dividends	N/A	¥0.20	¥0.00	¥0.18	¥0.21	¥0.18	¥0.15	¥0.10	¥0.00	¥0.00
PR %	Payout Ratio %	0	45.45%	0	45.00%	39.62%	54.55%	57.69%	52.63%	0	0
Sha.	Shares	N/AM	757.11M	758.26M	788.69M	788.69M	682.26M	628.35M	628.35M	628.35M	628.35M
OCF	Operating Cash Flow	N/A	¥356.08M	¥409.94M	¥311.16M	¥476.62M	¥241.97M	¥213.33M	¥140.24M	¥0.00M	¥0.00M
FCF	Free Cash Flow	N/A	¥290.60M	¥251.21M	¥107.71M	¥265.80M	¥29.32M	¥90.11M	¥97.39M	¥0.00M	¥0.00M
FCFS	Free Cash Flow Per Share	¥0.35	¥0.39	¥0.33	¥0.14	¥0.34	¥0.05	¥0.14	¥0.15	¥0.04	¥0.17

KPC Pharmaceuticals,Inc financials at a glance

Financials

Discover